Adalimumab is distinguished from Infliximab primarily because Adalimumab is:
Show answer and explanation
Correct answer: A fully human monoclonal antibody
Adalimumab ('-umab') is a fully human IgG1 monoclonal antibody produced by phage display technology. Being fully human, it generally has a lower risk of inducing neutralizing antibodies (HACA) compared to chimeric antibodies like Infliximab.
Keep practicing
More Monoclonal Antibodies questions
- What is the specific target of Cetuximab in the treatment of colorectal and head and neck cancers?
- Eculizumab is used in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) by targeting which component?
- The monoclonal antibody Palivizumab is used as prophylaxis in high-risk infants to prevent infection from which pathogen?
- Which of the following antibodies targets IL-17A and is used to treat plaque psoriasis?
- What is the primary target of the monoclonal antibody Ipilimumab in cancer immunotherapy?
- Tocilizumab is a monoclonal antibody that blocks the receptor for which pro-inflammatory cytokine?